The impact of coding germline variants on contralateral breast cancer risk and survival.
Anna Morra,
Nasim Mavaddat,
Taru A Muranen,
Thomas U Ahearn,
Jamie Allen,
Irene L Andrulis,
Päivi Auvinen,
Heiko Becher,
Sabine Behrens,
Carl Blomqvist,
Stig E Bojesen,
Manjeet K Bolla,
Hiltrud Brauch,
Nicola J Camp,
Sara Carvalho,
Jose E Castelao,
Melissa H Cessna,
Jenny Chang-Claude,
Georgia Chenevix-Trench,
Kamila Czene,
Brennan Decker,
Joe Dennis,
Thilo Dörk,
Leila Dorling,
Alison M Dunning,
Arif B Ekici,
Mikael Eriksson,
D Gareth Evans,
Peter A Fasching,
Jonine D Figueroa,
Henrik Flyger,
Manuela Gago-Dominguez,
Montserrat García-Closas,
Willemina R R Geurts-Giele,
Graham G Giles,
Pascal Guénel,
Melanie Gündert,
Eric Hahnen,
Per Hall,
Ute Hamann,
Patricia A Harrington,
Wei He,
Päivi Heikkilä,
Maartje J Hooning,
Reiner Hoppe,
Anthony Howell,
Keith Humphreys,
Anna Jakubowska,
Audrey Y Jung,
Renske Keeman,
Vessela N Kristensen,
Jan Lubiński,
Arto Mannermaa,
Mehdi Manoochehri,
Siranoush Manoukian,
Sara Margolin,
Dimitrios Mavroudis,
Roger L Milne,
Anna Marie Mulligan,
William G Newman,
Tjoung-Won Park-Simon,
Paolo Peterlongo,
Paul D P Pharoah,
Valerie Rhenius,
Emmanouil Saloustros,
Elinor J Sawyer,
Rita K Schmutzler,
Mitul Shah,
Amanda B Spurdle,
Ian Tomlinson,
Thérèse Truong,
Elke M van Veen,
Maaike P G Vreeswijk,
Qin Wang,
Camilla Wendt,
Xiaohong R Yang,
Heli Nevanlinna,
Peter Devilee,
Douglas F Easton,
Marjanka K Schmidt
Mar 28, 2023
Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of...